NSPR News and Press, InspireMD Inc. From 05/11/21

InspireMD, Inc. (NSPR) Q1 2021 Earnings Conference Call May 11, 2021, 08:30 AM ET Company Participants Scott Gordon - President, Core IR, IR Marvin Slosman - CEO Craig Shore - CFO Conference Call Participants Benjamin Haynor - Alliance Global Partners Presentation Operator Ladies and gentleme...

InspireMD (NSPR): Q1 GAAP EPS of -$0.53 beats by $0.07.Revenue of $1.01M (-1.9% Y/Y) beats by $0.11M.Cash and cash equivalents of $44.0MShares -5.70% PM.Press Release For further details see: InspireMD EPS beats by $0.07, beats on revenue

Company Completes Up-List to Nasdaq Capital Market, with Trading Becoming Effective May 21, 2021 Management to host investor conference call today, May 11, 2021, at 8:30am ET TEL AVIV, Israel, May 11, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR)...

TEL AVIV, Israel, May 10, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced the Company’s shares have be...

TEL AVIV, Israel, May 06, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), announced today that management will participate at ...

TEL AVIV, Israel, May 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) (“InspireMD” or the “Company”), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today...

TEL AVIV, Israel, April 29, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of the stroke caused by carotid artery disease, today announces the formation of its Scientific Advisory Board with ...

ADMA Biologics (ADMA) +25% after receiving FDA approval for increased IVIG production scale.Akari Therapeutics (AKTX) +12% on receiving FDA fast track designation for Nomacopan.Sphere 3D Corp. (ANY) +12%.RiceBran Technologies (RIBT) +11%.Boxlight Corporation (BOXL) +11%.Calliditas T...

Shares of InspireMD Inc. (NYSE American:NSPR) traded at a new 52-week high today of $7.32. So far today approximately 8.8 million shares have been exchanged, as compared to an average 30-day volume of 5.6 million shares. InspireMD Inc is the United States based medical device company. It...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amazon (NASDAQ: AMZN ) stock is rallying higher on Tuesday after speculative Tweets about a possible stock split sent shares soaring on Monday. Source: Quisquilia / Shutterstock.com The Tweets in question come f...